Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Suriname Tech News.
Press releases published on April 28, 2025
SELLAS Unveils Breakthrough Preclinical Data Highlighting Efficacy of SLS009 in TP53 Mutated AML at the 2025 AACR Conference
GlobeNewswire
·
April 28, 2025
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
AI Lifecycle Automation Leader ModelOp Strengthens Its Commitment to Trustworthy and Ethical AI in Healthcare by Joining the Coalition for Health AI (CHAI)
GlobeNewswire
·
April 28, 2025
As a member of CHAI, ModelOp joins a diverse network of industry leaders, healthcare providers, academic institutions, and technology organizations working together to establish best practices and frameworks that ensure the safe and equitable deployment of …
One Stop Systems to Report First Quarter 2025 Financial Results
GlobeNewswire
·
April 28, 2025
ESCONDIDO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (“OSS” or the “Company”) (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, …
Intent IQ Announces Availability of Bid Enhancement Solution on Google Cloud Marketplace
GlobeNewswire
·
April 28, 2025
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Intent IQ, a privacy-forward, next-generation identity resolution leader, today announced Intent IQ’s innovative Bid Enhancement solution is now available on Google Cloud Marketplace. As a result, Google Cloud …
New MetaMask Metal Payment Card: Self-Custody Crypto Card With Direct Payments Unveiled by CompoSecure, Baanx and MetaMask
GlobeNewswire
·
April 28, 2025
SOMERSET, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (“CompoSecure”) (NASDAQ: CMPO), a leader in metal payment cards, security, and authentication solutions, in collaboration with Baanx and MetaMask, today announced the launch of the …
reAlpha Tech Corp. Appoints Cristol Rippe as CMO
GlobeNewswire
·
April 28, 2025
DUBLIN, Ohio, April 28, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), a real estate technology company developing and commercializing artificial intelligence (“AI”) technologies, is pleased to announce the …
Jiayin Group Inc. Filed Annual Report on Form 20-F for Fiscal Year 2024
GlobeNewswire
·
April 28, 2025
SHANGHAI, China, April 28, 2025 (GLOBE NEWSWIRE) -- Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced that it has filed its annual report on Form 20-F (the "Annual Report") for the fiscal …
SEALSQ Organizes French Quantum and Space Day: Leading Experts in Quantum, Post-Quantum, and Space Security Gather near Marseille for a Unique Technology Showcase
GlobeNewswire
·
April 28, 2025
Geneva, Switzerland, April 28, 2025 (GLOBE NEWSWIRE) -- Public Event to be Held on May 13, 2025, at Hotel Le Fregate, Saint-Cyr-sur-Mer, France SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling …
NobleAI to Present at 2025 AOCS Annual Meeting
GlobeNewswire
·
April 28, 2025
PORTLAND, Ore., April 28, 2025 (GLOBE NEWSWIRE) -- NobleAI, the leader in practical AI solutions for innovation in the chemicals and energy industries, today announced that it will present with ExxonMobil at the upcoming American Oil Chemists' Society ( …
iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring
GlobeNewswire
·
April 28, 2025
Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups. Latest data showed Zio LTCM was associated with higher diagnostic yield and …
Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval
GlobeNewswire
·
April 28, 2025
BERKELEY, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major accomplishments of the …
Rigetti Granted Air Force Office of Scientific Research Award to Further Develop Breakthrough Chip Fabrication Technology
GlobeNewswire
·
April 28, 2025
The $5.48 million Rigetti-led consortium will include Iowa State University, the Royal Melbourne Institute of Technology, the University of Connecticut, and Lawrence Livermore National Laboratory. The project aims to develop a deeper understanding of how …
80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting
GlobeNewswire
·
April 28, 2025
80% of EVX-01 vaccine targets triggered a tumor-specific immune response, a substantially higher frequency than what has been reported for other similar vaccine candidates The data underscores the precision of Evaxion’s AI-Immunology™ platform in selecting …
ImPact Biotech Presents Updated Efficacy Data from Evaluation of Padeliporfin VTP in LG UTUC and Intermediate-Risk Prostate Cancer at AUA 2025
GlobeNewswire
·
April 28, 2025
– Complete response (CR) observed in 79% (26/33) of evaluable patients with low-grade upper tract urothelial cancer (UTUC) who completed the Induction Treatment Phase (ITP) of the ENLIGHTED Phase 3 trial evaluating Padeliporfin VTP in UTUC – – Padeliporfin …
Pacira BioSciences Announces Two-Year Efficacy Data Following a Single Local Administration of PCRX-201 in Patients with Mild to Severe Osteoarthritis of the Knee
GlobeNewswire
·
April 28, 2025
-- PCRX-201 demonstrated two years of clinically meaningful improvements in pain, stiffness and function across all structural severity subgroups, including advanced disease -- -- Study Findings Presented at 2025 OARSI World Congress-- BRISBANE, Calif., …
Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
GlobeNewswire
·
April 28, 2025
DURHAM, N.C., April 28, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the first quarter of fiscal year 2025 …
BigCommerce and Silk Commerce Launch Distributed Ecommerce Hub to Power Scalable Storefront Networks for Dealers, Distributors and Franchises
GlobeNewswire
·
April 28, 2025
AUSTIN, Texas, April 28, 2025 (GLOBE NEWSWIRE) -- BigCommerce (Nasdaq: BIGC), an open SaaS, composable ecommerce platform for fast-growing and established B2C and B2B brands and retailers, today announced the launch of Distributed Ecommerce Hub, a new …
Bright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 Study
GlobeNewswire
·
April 28, 2025
VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”), a company focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant …
Quanta Therapeutics Presents Late-Breaking Data for QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, at AACR Annual Meeting 2025
GlobeNewswire
·
April 28, 2025
- Preclinical data demonstrates synergy of QTX3544 with EGFR inhibitors, broadly enhancing anti-tumor activity - - Data supports ongoing Phase 1 clinical trial for QTX3544 as monotherapy and in combination with cetuximab in patients with KRASG12V mutations …
Calidi Biotherapeutics Announces IL15 Superagonist as First Payload to be Delivered by Systemic Antitumor Virotherapy Platform at AACR Annual Meeting
GlobeNewswire
·
April 28, 2025
SAN DIEGO, April 28, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the selection of IL15 …